Tumor-infiltrating lymphocytes to predict survival to anthracycline/taxane-based adjuvant chemotherapy in triple negative breast cancer.

被引：0
|
作者：
Ou, Qiyun
Yu, Yunfang
Xiao, Xiaoyun
Luo, Baoming
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasonog, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens
    Wang, Shusen
    Shi, Yanxia
    Yuan, Zhongyu
    Wang, Xi
    Liu, Donggen
    Peng, Roujun
    Teng, Xiaoyu
    Qin, Tao
    Peng, Jiewen
    Lin, Guinan
    Jiang, Xiaomei
    [J]. MEDICAL ONCOLOGY, 2012, 29 (02) : 547 - 553
  • [22] Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer
    Bacinschi, Xenia Elena
    Zgura, Anca
    Safta, Inga
    Anghel, Rodica
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11965 - 11971
  • [23] Evaluation of tumor-infiltrating lymphocytes on matched baseline and residual disease samples of triple-negative breast cancer patients treated with anthracycline-taxane based neoadjuvant chemotherapy with or without carboplatin
    Miglietta, F.
    Zarrilli, G.
    Massa, D.
    Griguolo, G.
    Fassan, M.
    Bottosso, M.
    Giorgi, C. A.
    Giarratano, T.
    Vernaci, G.
    Cesarotto, M.
    Guarascio, M. C.
    Guarneri, V.
    Dieci, M. V.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S135 - S136
  • [24] Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
    Geurts, Veerle C. M.
    Balduzzi, Sara
    Steenbruggen, Tessa G.
    Linn, Sabine C.
    Siesling, Sabine
    Badve, Sunil S.
    DeMichele, Angela
    Ignatiadis, Michail
    Leon-Ferre, Roberto A.
    Goetz, Matthew P.
    Wolff, Antonio C.
    Klar, Natalie
    Michiels, Stefan
    Loi, Sherene
    Adams, Sylvia
    Horlings, Hugo M.
    Sonke, Gabe S.
    Salgado, Roberto
    Kok, Marleen
    [J]. JAMA ONCOLOGY, 2024,
  • [25] Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    Lee, Hyun
    Lee, Miseon
    Seo, Jeong-Han
    Gong, Gyungyub
    Lee, Hee Jin
    [J]. ANTICANCER RESEARCH, 2020, 40 (04) : 1883 - 1890
  • [26] Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
    Garcia-Teijido, Paula
    Luque Cabal, Maria
    Pelaez Fernandez, Ignacio
    Fernandez Perez, Yolanda
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 31 - 39
  • [27] Tumor-Infiltrating Lymphocytes and Response to Platinum in Triple-Negative Breast Cancer
    Tung, Nadine M.
    Winer, Eric P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 969 - +
  • [28] Functional mechanism on tumor-infiltrating lymphocytes in triple-negative breast cancer
    Kai, M.
    Mori, H.
    Kawaji, H.
    Kurata, K.
    Yamada, M.
    Kubo, M.
    Nakamura, M.
    [J]. BREAST, 2019, 44 : S96 - S96
  • [29] Clinical Significance of Stromal Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer
    Goel, Kanika
    Carter, Gloria
    Clark, Beth
    Fine, Jeffrey
    Yu, Jing
    Harinath, Lakshmi
    Villatoro, Tatiana
    Bhargava, Rohit
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 117 - 119
  • [30] Clinical Significance of Stromal Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer
    Goel, Kanika
    Carter, Gloria
    Clark, Beth
    Fine, Jeffrey
    Yu, Jing
    Harinath, Lakshmi
    Villatoro, Tatiana
    Bhargava, Rohit
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 117 - 119
12345